June 28, 2021 Uncategorized

Roche’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)

ENSPRYNG is the first and only treatment approved for both adults and adolescents in the EU with AQP4-IgG seropositive NMOSD ENSPRYNG can be used as a monotherapy or in combination with immunosuppressive therapy to reduce relapses and prevent permanent disability In Phase III studies, ENSPRYNG significantly reduced the number and severity of relapses in people... Read more

June 24, 2021 Uncategorized

GE Healthcare and Wayra select five AI-led healthtech start-ups for first Edison™ Accelerator

The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Five healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more

June 24, 2021 Uncategorized

GE Healthcare and Wayra select six AI-led healthtech start-ups for EMEA Edison™ Accelerator

The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Six healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more

June 15, 2021 Uncategorized

Roche data at EAN 2021 showcase significant impact of therapies across diverse neuroscience portfolio

Data for EVRYSDI reinforce safety profile and efficacy in a broad spinal muscular atrophy (SMA) population, following recent EU approval Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) build on safety profile and efficacy following recent CHMP opinion, including in adults with concomitant autoimmune diseases (CAIDs) OCREVUS data continue to show consistent benefit on... Read more

May 25, 2021 Uncategorized

24 Hours of Life Science Conference

On June 2, 2021, JEOL will focus on advances in life science research using electron microscopy in its “24 Hours of Life Science” conference. Twenty-four different sessions throughout the full day will cover topics including: – Connectomics and the study of complete volumes of tissues or materials captured at high resolution– Correlative microscopy using light... Read more

May 12, 2021 Uncategorized

MKS Instruments Increases Quarterly Cash Dividend

ANDOVER, Mass., May 12, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, a ten percent Read more

May 6, 2021 Uncategorized

GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients

GE Healthcare to scale Zionexa’s FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18), used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer Aims to make Cerianna available to 75% of metastatic breast cancer patients in the U.S.... Read more